NEW YORK (Reuters Health) – Women with polycystic ovary syndrome have increased levels of LDL-cholesterol and non-HDL-cholesterol, as well as more widely recognized alterations in triglycerides and HDL…
NEW YORK (Reuters Health) – Neither injectable nor oral contraceptives have a meaningful effect on glucose or insulin levels, researchers report in the January 2011 Obstetrics & Gynecology.…
NEW YORK (Reuters Health) – In comparison with results in adults with diabetes, hemoglobin A1c (HbA1C) testing in younger patients doesn’t have the same level of discrimination, researchers…
NEW YORK (Reuters Health) – The clinical efficacy of rituximab in rheumatoid arthritis (RA) depends on the degree of B cell depletion rather than the dose of rituximab,…
NEW YORK (Reuters Health) – The response rate to high-dose pulsed intravenous glucocorticoid therapy is about 80% for patients with active Graves’ orbitopathy, German clinicians report. However, they…
NEW YORK (Reuters Health) – The transvenous high-voltage leads of Medtronic’s Sprint Fidelis implantable cardioverter-defibrillator continue to deteriorate more rapidly than the earlier Medtronic Quattro Secure ICD leads,…
NEW YORK (Reuters Health) – For children with bleeding disorders who experience head trauma, cranial CT scans are usually not necessary if symptoms are absent, investigators report in…
NEW YORK (Reuters Health) – Results of a large randomized, double-blind study suggest that the TNF inhibitor etanercept (Enbrel; Pfizer) may be more efficacious than sulfasalazine in the…
NEW YORK (Reuters Health) – Intravenous immunoglobulin (IVIG) is not helpful in the treatment of women with unexplained recurrent miscarriage and, for now, should not be used outside…
NEW YORK (Reuters Health) – In patients with chronic kidney disease (CKD), an impaired platelet response clopidogrel independently contributes to worse outcomes after percutaneous coronary intervention (PCI), a…